What is Glooko?
Glooko operates at the intersection of healthcare technology and patient empowerment, offering a sophisticated, intelligent, and connected care platform designed to improve the health outcomes of individuals with chronic conditions. The company's proven technologies focus on revolutionizing the connection between patients and healthcare providers, driving enhanced patient engagement and adherence through digital therapeutics. Furthermore, Glooko's platform plays a crucial role in accelerating the speed and efficiency of clinical trials by providing real-world data and insights.
The company's approach leverages digital tools to bridge the gap in chronic disease management, making lives better by fostering a more integrated and data-driven healthcare ecosystem.
How much funding has Glooko raised?
Glooko has raised a total of $190.5M across 7 funding rounds:
Angel/Seed
$1M
Series A
$7M
Series B
$16.5M
Series C
$35M
Debt
$1M
Series D
$30M
Series F
$100M
Angel/Seed (2011): $1M with participation from Social+Capital, Andy Hertzfeld, Russel Hirsch, Vint Cerf, Anand Agarawala, Xtreme Labs, Judy Estrin, Bill Campbell, Venky Harinarayan, and Annad Rajarman
Series A (2014): $7M led by The Social+Capital Partnership and Samsung Ventures
Series B (2015): $16.5M supported by Samsung Ventures, Medtronic, The Social + Capital Partnership, and Canaan Capital
Series C (2017): $35M featuring Canaan Partners, Insulet, Samsung NEXT, Medtronic, Mayo Clinic, and Georgian
Debt (2020): $1M backed by PPP
Series D (2021): $30M with participation from Health Catalyst Capital Management, Insulet, Mayo Clinic, Novo Nordisk, Canaan Partners, and Georgian
Series F (2024): $100M led by Georgian and Health Catalyst Capital Management
Key Investors in Glooko
Health Catalyst Capital Management
Health Catalyst Capital is a private equity firm specializing in high-growth healthcare information technology and tech-enabled services businesses, aiming to enhance care quality and affordability through technological solutions.
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, biopharma, and digital health.
Medtronic
Medtronic is a global medical technology company that designs, manufactures, and sells device-based medical therapies across multiple segments including diabetes care, advancing its mission to alleviate pain, restore health, and extend life through technology.
What's next for Glooko?
With the recent major strategic investment, Glooko is poised for accelerated expansion and innovation in the digital health landscape. The company's focus on connected care and digital therapeutics for chronic conditions positions it to capitalize on the growing demand for remote patient monitoring and personalized health solutions. Future developments are likely to involve further enhancement of its platform's AI capabilities, broader integration with healthcare systems, and expansion into new therapeutic areas.
The substantial backing from strategic investors signals strong confidence in Glooko's business model and its potential to significantly impact global health outcomes. This capital will likely fuel product development, market penetration, and strategic partnerships, solidifying Glooko's role as a leader in transforming chronic disease management.
